Stacked rolled newspapers with black and white text and images.

Newsroom

Meliodays’ hub for providing you with the latest press releases, news, background stories, and further press material for download.

Contact for media enquiries

Trudy Au
VP Brand Marketing & Communications
communications@meliodays.com

News & Updates

23.06.2026

Meliodays Medical Named "Start-up of the Year" at the Saxon Founder Award

Meliodays was recognized as Start-up of the Year at the Saxon Innovation Conference, selected from 116 applications for its hormone-free approach to treating menstrual pain. The award adds to Meliodays' growing presence in Leipzig's life sciences ecosystem, following the company's earlier selection for the medical:forge medtech accelerator.

18.12.2025

Meliodays Medical Announces Positive Preclinical Results on MelioOne®

Meliodays’ recent pharmacokinetic (PK) study explored the feasibility of local, sustained Celecoxib delivery via a novel intrauterine device to minimize systemic exposure while maintaining local therapeutic levels.

18.11.2025

SZ Gipfelstürmer Award Winner: Meliodays Medical for a Therapy Against Menstrual Pain

Meliodays won in the Health category of SüddeutscheZeitung’s GipfelSturmer Awards 2025. Meliodays has developed a non-hormonal, locally acting therapy that releases painkillers directly into the uterus to alleviate menstrual pain.

20.03.2025

Meliodays Medical announces the closing of a pre-seed financing round of over €800,000

Addressing a high unmet medical need in menstrual pain with microdoses of painkillers through local application

New partnership announcement between Celanese and Meliodays, featuring a visual of an intrauterine device

29.07.2025

Meliodays and Celanese partner for Meliodays’ development of hormone-free non-contraceptive IUD designed to treat Menstrual Pain

Celanese’s VitalDose® Drug Delivery Platform will enable a long-acting, patient-centric formulation for Meliodays’ IUD design